11.07.16
UPS has entered into a definitive agreement to acquire Marken, a global provider of supply chain services to the life sciences industry. The transaction, subject to customary closing conditions, is expected to close by December 31. Financial details and terms were not disclosed.
Marken operates a global network of clinical supply chain services to meet increasingly complex regulatory compliance demands for clients.
UPS has been expanding its healthcare logistics services portfolio through several recent acquisitions.
“Healthcare logistics is a strategic market for UPS. Our acquisition of Marken strengthens our portfolio and demonstrates our commitment to customers,” said Teresa Finley, UPS chief marketing and business services officer. “We plan to offer new solutions to our customers and generate further growth opportunities for UPS.”
“We are excited to join the UPS organization,” said Wes Wheeler, Marken’s chief executive officer. “UPS’s capabilities, particularly in mature markets, will provide many opportunities for us to enhance our service offerings in clinical trials logistics. With UPS, we will improve our efficiency, while continuing to provide our clients with the high-touch, personalized services that they have come to expect from us.”
Mr.Wheeler will continue to lead the Marken business, which will operate as a wholly-owned subsidiary of UPS.
Marken operates a global network of clinical supply chain services to meet increasingly complex regulatory compliance demands for clients.
UPS has been expanding its healthcare logistics services portfolio through several recent acquisitions.
“Healthcare logistics is a strategic market for UPS. Our acquisition of Marken strengthens our portfolio and demonstrates our commitment to customers,” said Teresa Finley, UPS chief marketing and business services officer. “We plan to offer new solutions to our customers and generate further growth opportunities for UPS.”
“We are excited to join the UPS organization,” said Wes Wheeler, Marken’s chief executive officer. “UPS’s capabilities, particularly in mature markets, will provide many opportunities for us to enhance our service offerings in clinical trials logistics. With UPS, we will improve our efficiency, while continuing to provide our clients with the high-touch, personalized services that they have come to expect from us.”
Mr.Wheeler will continue to lead the Marken business, which will operate as a wholly-owned subsidiary of UPS.
